Riskpilot← Back to searchSign inGet full accessDuMed A/S
A/SActiveCVR 17912798Kokholm 3C, st. tvWholesale of pharmaceutical and medical goods · NACE 4646Est. 19947 employeeswww.dumedgroup.com
Revenue 2025
DKK 6,4M
-2% vs 2024
EBITDA margin
9.7%
-13% vs 2024
Equity ratio
-1.6%
Financial strength
Net profit 2025
DKK 1,2M
+166% vs 2024
| Revenue | DKK 6,4M | -2% |
| EBITDA | DKK 623K | -13% |
| Net profit | DKK 1,2M | +166% |
| Total assets | DKK 6,2M | +15% |
| Equity | DKK -101K | +92% |
| Employees | 7 | — |
Legal name
DuMed A/S
CVR number
17912798
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30. juni 1994
Share capital
DKK 500.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør sammen med bestyrelsesformanden eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at forestå markedsføring og salg af produkter indenfor medicinalindustrien samt dermed beslægtede aktiviteter.
Address
Kokholm 3C, st. tv
Phone
+4597267900
Email
info@dumedgroup.com
Website
www.dumedgroup.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.347 | 5.647 | 4.814 | 4.075 | 3.426 | 2.643 | 4.946 | 4.431 | 5.483 | 5.163 | 7.435 | 7.286 | 6.549 | 6.394 |
| Staff expenses | -4.352 | -4.421 | -3.993 | -3.745 | -2.813 | -2.846 | -4.148 | -4.884 | -4.619 | -5.657 | -6.842 | -6.812 | -5.833 | -5.771 |
| EBITDA | 1.995 | 1.226 | 821 | 330 | 613 | -203 | 798 | -463 | 864 | -493 | 593 | 152 | 716 | 623 |
| Depreciation & amort. | -58 | -206 | -203 | -132 | -162 | -327 | -217 | -212 | -112 | -158 | -199 | -176 | -50 | -12 |
| EBIT | 1.937 | 1.020 | 618 | 198 | 452 | -530 | 581 | -675 | 752 | -652 | 394 | -23 | 666 | 611 |
| Net financials | -3 | 2 | 13 | 5 | 6 | -21 | -58 | 54 | -44 | -31 | -51 | 112 | -2.478 | 693 |
| Profit before tax | 1.934 | 1.023 | 632 | 203 | 458 | -550 | 523 | -622 | 708 | -682 | 342 | 89 | -1.812 | 1.304 |
| Tax | 496 | 260 | 161 | 53 | 106 | -119 | 119 | -166 | 155 | -149 | 74 | 34 | -7 | 108 |
| Net profit | 1.439 | 762 | 470 | 151 | 352 | -432 | 404 | -456 | 552 | -534 | 268 | 55 | -1.804 | 1.195 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 11.406 | 7.283 | 5.596 | 4.440 | 5.061 | 4.611 | 4.745 | 5.533 | 6.049 | 4.888 | 6.033 | 9.484 | 5.377 | 6.195 |
| Equity | 2.647 | 2.809 | 2.430 | 2.479 | 2.831 | 496 | 900 | 194 | 752 | 215 | 467 | 521 | -1.291 | -101 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 1.008 | 1.000 | 1.174 | 282 | 0 | 0 | 548 | 1.632 | 1.232 |
| Short-term debt | 8.729 | 4.337 | 3.166 | 1.957 | 2.194 | 3.108 | 2.846 | 4.165 | 5.015 | 4.673 | 5.567 | 8.416 | 5.035 | 5.014 |
| Total debt | 8.729 | 4.337 | 3.166 | 1.957 | 2.194 | 4.115 | 3.846 | 5.339 | 5.298 | 4.673 | 5.567 | 8.964 | 6.668 | 6.246 |
EBITDA margin
9.7%
This company
15.8%
Market median
-39% vs market
20122025
Equity ratio
-1.6%
This company
38.2%
Market median
-104% vs market
20122025
Return on equity
119538100.0%
This company
18.4%
Market median
+649663487% vs market
20122025
Net profit margin
18.7%
This company
8.1%
Market median
+131% vs market
20122025
Asset turnover
1.03×
This company
1.12×
Market median
+8% vs market
20122025
Debt / equity
62.34×
This company
0.62×
Market median
-9955% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JP Founder | Founder | 1994 | — | — |
LP Founder | Founder | 1994 | — | — |
TE Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 1994 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Norse Medical A/S | Company | 50.0% | 50.0% | 2020 |
BamZe ApS | Company | 15.0% | 15.0% | 2021 |
JE Vejle Holding ApS | Company | 10.0% | 10.0% | 2020 |
Meonto Holding ApS | Company | 10.0% | 10.0% | 2020 |
LPZ KOLDING HOLDING ApS | Company | 15.0% | 15.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BamZe ApS
DuMed A/S Board members of DuMed A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Peder Jensen | Founder | 0 companies |
| Lars Preben Zeidler | Founder | 0 companies |
| Thomas Emborg Kreutzfeldt | Chief Executive Officer | 0 companies |
| Lars Laustsen Gleerup | Chairman | 0 companies |
| Erik Sejersen | Board of Directors | 0 companies |
| Peter Schack | Board of Directors | 0 companies |
| Janny Elmholdt | Board of Directors | 0 companies |
| Søren Thygesen | Board of Directors | 0 companies |
| Mads Zeidler | Board of Directors | 0 companies |